NCT07249749 Factor Associated With Mortality in the ICU
| NCT ID | NCT07249749 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Hospital Departamental de Villavicencio |
| Condition | Critically Ill |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2026-01-10 |
| Primary Completion | 2028-12-20 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,000 participants in total. It began in 2026-01-10 with a primary completion date of 2028-12-20.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
ICU mortality indicates the severity of disease, healthcare quality, and the efficacy of interventions. The severity scores are tools to predict the risk of mortality in the ICU, and the APACHE II score is frequently used for this purpose. However, studies validating the score in Colombia are limited. There is uncertainty about the precision and discrimination capacity of the APACHE II score in a population that varies from the original, with varying diseases, and in a different timeline. The investigators determined to evaluate: 1. Evaluate the rate of mortality in the ICU by type of disease and type of admission. 2. The factors associated with mortality. 3. Validate the performance of the APACHE II score as a predictor of mortality.
Eligibility Criteria
Inclusion Criteria: * All adult patients older than 18 admitted to the intensive care unit during the study period. Exclusion Criteria: * Patients admitted for intermediate care (low therapeutic intervention with a TISS \[Therapeutic Intervention Scoring System\] - 28 score below 20 points). Patients derived to other institutions.
Contact & Investigator
Norton Perez Gutierrez, MD
PRINCIPAL INVESTIGATOR
Hospital Departamental de Villavicencio
Frequently Asked Questions
Who can join the NCT07249749 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 100 Years, studying Critically Ill. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07249749 currently recruiting?
Yes, NCT07249749 is actively recruiting participants. Contact the research team at norton.perez@hotmail.com for enrollment information.
Where is the NCT07249749 trial being conducted?
This trial is being conducted at Villavicencio, Colombia.
Who is sponsoring the NCT07249749 clinical trial?
NCT07249749 is sponsored by Hospital Departamental de Villavicencio. The principal investigator is Norton Perez Gutierrez, MD at Hospital Departamental de Villavicencio. The trial plans to enroll 1,000 participants.